LASO-3 Diet for Peripheral Neuropathy

This trial tests whether the LASO-3 Diet Intervention can reduce nerve problems, such as numbness and tingling, in cancer survivors who underwent chemotherapy. The diet emphasizes reducing sugar, increasing fiber, and consuming foods high in omega-3s (like certain fish or plant oils) to combat inflammation. Participants will attend virtual sessions with a dietitian to learn and adopt these eating habits. The trial seeks cancer survivors who continue to experience nerve issues at least three months post-chemotherapy, have internet access, and do not already consume large amounts of fish or sweets. As an unphased trial, this study provides a unique opportunity to explore dietary changes that may enhance the quality of life for cancer survivors.

The trial does not specify if you need to stop taking your current medications, but you cannot start a new prescription of duloxetine during the study. Also, you cannot routinely use NSAIDs or steroids.

Research has shown that the LASO-3 diet, which involves reducing sugar intake, increasing fiber, and consuming more omega-3s, is generally safe. This diet aims to alleviate chemotherapy-induced peripheral neuropathy (CIPN), a condition that causes numbness or tingling in the hands or feet of many cancer survivors.

Researchers closely monitor participants in similar studies for safety, and no major side effects have been reported so far. The diet aligns with the United States Dietary Guidelines, which are well-known and considered safe. Increasing fiber, reducing sugar, and boosting omega-3 intake are common dietary recommendations and are usually manageable for most people.

Researchers are excited about the LASO-3 Diet for peripheral neuropathy because it offers a unique, nutrition-focused approach that could complement or even enhance current treatment options like medications and physical therapy. Unlike traditional treatments that primarily aim to relieve symptoms, the LASO-3 Diet focuses on dietary changes and personalized nutrition counseling to address the condition more holistically. This method could potentially improve nerve health from the inside out, offering a new avenue for managing peripheral neuropathy beyond the standard care.

Research shows that dietary changes can help manage chemotherapy-induced peripheral neuropathy (CIPN). CIPN results from nerve damage caused by chemotherapy, leading to numbness, tingling, or pain in the hands or feet. In this trial, participants in one arm will follow the LASO-3 diet, which reduces added sugars, increases fiber, and boosts omega-3 fatty acids, all known to lower inflammation. Studies have found that reducing inflammation can help with nerve-related symptoms. While researchers are still studying direct evidence for LASO-3's effectiveness in treating CIPN, its components support nerve health and reduce inflammation, suggesting potential benefits.¹²⁶⁷⁸